Lupus Nephritis Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com

Lupus Nephritis Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com
Dallas, TX (PRWEB) June 10, 2015 The report “Lupus Nephritis – Pipeline Review, H1 2015” provides comprehensive information on the therapeutic development for Lupus Nephritis. Lupus nephritis is kidney inflammation caused by systemic lupus erythematosus. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report on ...

Food Allergy Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com

Food Allergy Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com
Dallas, Texas (PRWEB) May 04, 2015 The report “Food Allergy – Pipeline Review, H1 2015” provides comparative analysis on the therapeutic development for Food Allergy. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report on H1 2015 pipeline review of Food Allergy with 18 market ...

Optic Neuritis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com

Optic Neuritis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com
(PRWEB) April 22, 2015 The report “Optic Neuritis – Pipeline Review, H1 2015” provides comparative analysis on the therapeutic development for Optic Neuritis. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report with TOC is available @ http://www.rnrmarketresearch.com/optic-neuritis-pipeline-review-h1-2015-market-report.html . The report also reviews key ...

Hemorrhagic Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com

Hemorrhagic Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com
Dallas, Texas (PRWEB) April 06, 2015 RnRMarketResearch.com adds “Hemorrhagic Shock – Pipeline Review, H1 2015” to its store. The report provides an overview of the Hemorrhagic Shock’s therapeutic pipeline. The report “Hemorrhagic – Pipeline Review, H1 2015” provides comparative analysis on the therapeutic development for this issue. A hemorrhagic stroke is usually associated with ...

Pruritus Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com

Pruritus Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com
Dallas, Texas (PRWEB) April 07, 2015 The report “Pruritus – Pipeline Review, H1 2015” provides comparative analysis on the therapeutic development for Pruritus. Pruritus is a common symptom, rather than a specific disease entity, that occurs in a diverse range of skin diseases and may appear as a prominent feature of extracutaneous disorders such as ...

Glaucoma Therapeutic Pipeline Companies and Drugs Review H1 2015 Report at RnRMarketResearch.com

Glaucoma Therapeutic Pipeline Companies and Drugs Review H1 2015 Report at RnRMarketResearch.com
Dallas, TX (PRWEB) January 25, 2015 The report “Glaucoma – Pipeline Review, H1 2015” provides comprehensive information on the therapeutic development for Glaucoma. Glaucoma is caused because of the pressure inside the eye. The primary function of the optic nerve is to send images to the brain. Permanent loss of vision can occur if this ...

Catalent and SELLAS Sign Exclusive Agreement for Therapeutic Reprofiling of Zolpidem

Somerset, N.J. (PRWEB) December 04, 2014 Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it had reached an exclusive development and licensing agreement with Swiss-based development-stage biopharmaceutical company SELLAS Life Sciences Group (SELLAS), to support the development and therapeutic ...